We are live on
!
Find out more
HBW
Hazlett, Burt & Watson Portfolio holdings
AUM
$320M
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
+10.21%
1 Year Est. Return
+24.67%
3 Year Est. Return
+69.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$10.5M
(+10%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.23%
Holding
657
New
24
Increased
190
Reduced
86
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.34M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$635K |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$388K |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
+$346K |
| 5 |
Vanguard Mega Cap Value ETF
MGV
|
+$335K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$806K |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$338K |
| 3 |
Invesco Variable Rate Preferred ETF
VRP
|
+$336K |
| 4 |
Salesforce
CRM
|
+$150K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$143K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.35% |
| 2 | Financials | 10.58% |
| 3 | Healthcare | 10.11% |
| 4 | Consumer Staples | 7.06% |
| 5 | Industrials | 6.01% |
Similar funds
SGF
OPW
FPL
SAMT
FPWM
SAM
BWS
SA
Hazlett, Burt & Watson's Q4 2022 Portfolio in Review
As of Q4 2022, Hazlett, Burt & Watson held 657 positions worth $114M, up 10% from $103M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Hazlett, Burt & Watson's Q4 2022 filing shows 24 new, 190 increased, 86 reduced and 23 closed positions. Its largest new stake was United Therapeutics: 200 shares worth $56K. The largest sale was ExxonMobil, an estimated $806K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Hazlett, Burt & Watson's largest Q4 2022 buy was United Therapeutics: 200 shares worth $56K.
- Hazlett, Burt & Watson added most to Schwab US Dividend Equity ETF in Q4 2022, an estimated $1.34M increase.
- Hazlett, Burt & Watson's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $806K.
- Hazlett, Burt & Watson fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $338K.
- Hazlett, Burt & Watson's ten largest holdings make up 33% of its $114M portfolio in Q4 2022.
- Hazlett, Burt & Watson opened 24 new positions and closed 23 in Q4 2022.
- Hazlett, Burt & Watson's portfolio value rose 10% quarter-over-quarter to $114M.
Based on Hazlett, Burt & Watson's 13F filing for Q4 2022, filed 25 Jan 2023.